These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32671978)

  • 21. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.
    Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A
    Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence.
    Ke EE; Wu YL
    Ther Adv Respir Dis; 2016 Jun; 10(3):256-64. PubMed ID: 26929305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
    Wu CE; Chang CF; Huang CY; Yang CT; Kuo CS; Hsu PC; Chang JW
    BMC Cancer; 2021 Jul; 21(1):859. PubMed ID: 34315431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged survival with erlotinib followed by afatinib in a caucasian smoker with metastatic, poorly differentiated large cell carcinoma of the lung: a case report.
    Sala González MÁ
    Cancer Biol Ther; 2015; 16(10):1434-7. PubMed ID: 26186355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation.
    Yamaguchi O; Kaira K; Mouri A; Shiono A; Hashimoto K; Miura Y; Nishihara F; Murayama Y; Kobayashi K; Kagamu H
    Cancer Chemother Pharmacol; 2019 May; 83(5):817-825. PubMed ID: 30758646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metastatic Brain Tumor from Lung Adenocarcinoma Presenting a Unique Radiographic Pattern during Afatinib Treatment:A Case Report].
    Miyamoto J; Nakagawa T; Hirayama H
    No Shinkei Geka; 2018 Mar; 46(3):213-217. PubMed ID: 29567871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric metastasis from small cell lung cancer: a case report.
    Gao S; Hu XD; Wang SZ; Liu N; Zhao W; Yu QX; Hou WH; Yuan SH
    World J Gastroenterol; 2015 Feb; 21(5):1684-8. PubMed ID: 25663792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of small-cell lung cancer: incremental changes but hope for the future.
    Hann CL; Rudin CM
    Oncology (Williston Park); 2008 Nov; 22(13):1486-92. PubMed ID: 19133604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete Remission to Afatinib in a Patient Harboring a Novel Epidermal Growth Factor Mutation in De Novo Small-Cell Lung Cancer: A Case Report: Clinical Lung Cancer.
    Hochmair MJ; Illini O; Prosch H; Krenbek D; Valipour A
    Clin Lung Cancer; 2022 Jun; 23(4):e289-e292. PubMed ID: 34865962
    [No Abstract]   [Full Text] [Related]  

  • 30. First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer.
    Su PL; Chen CW; Wu YL; Lin CC; Su WC
    Thorac Cancer; 2021 Feb; 12(3):287-296. PubMed ID: 33336895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery for limited-stage small-cell lung cancer.
    Barnes H; See K; Barnett S; Manser R
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival.
    Chan RT
    Asia Pac J Clin Oncol; 2018 Mar; 14 Suppl 1():7-9. PubMed ID: 29508940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.
    Suda K; Murakami I; Sakai K; Mizuuchi H; Shimizu S; Sato K; Tomizawa K; Tomida S; Yatabe Y; Nishio K; Mitsudomi T
    Sci Rep; 2015 Sep; 5():14447. PubMed ID: 26400668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
    Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
    BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.
    Yang CJ; Tsai MJ; Hung JY; Lee MH; Tsai YM; Tsai YC; Hsu JF; Liu TC; Huang MS; Chong IW
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):82. PubMed ID: 29237484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Second-line chemotherapy and its survival analysis of 181 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):572-8. PubMed ID: 24229622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI).
    Tseng YH; Hung HY; Sung YC; Tseng YC; Lee YC; Whang-Peng J; Chen YM
    J Chemother; 2016; 28(1):50-8. PubMed ID: 25976428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Management of Patients with Advanced Epidermal Growth Factor Receptor Mutation Non-small Cell Lung Cancer: Role of Afatinib and Lesson Learned for Developing Countries.
    Amin Z; Jayalie VF; Rajabto W
    Acta Med Indones; 2017 Jan; 49(1):79-88. PubMed ID: 28450659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation.
    Suda K; Murakami I; Yu H; Kim J; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
    J Thorac Oncol; 2017 Jun; 12(6):1015-1020. PubMed ID: 28193529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival outcomes after whole brain radiotherapy for brain metastases in older adults with newly diagnosed metastatic small cell carcinoma: A national cancer database (NCDB) analysis.
    Renz P; Hasan S; Wegner RE
    J Geriatr Oncol; 2019 Jul; 10(4):560-566. PubMed ID: 30876834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.